| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |